Abstract

Autoantibodies against double-stranded DNA (anti-dsDNA) are a hallmark of systemic lupus erythematosus (SLE). It is well documented that anti-dsDNA reactive B lymphocytes are normally controlled by immune self-tolerance mechanisms operating at several levels. The evolution of high levels of IgG anti-dsDNA in SLE is dependent on somatic hypermutation and clonal selection, presumably in germinal centers from non-autoreactive B cells. Twin studies as well as genetic studies in mice indicate a very strong genetic contribution for the development of anti-dsDNA as well as SLE. Only few single gene defects with a monogenic Mendelian inheritance have been described so far that are directly responsible for the development of anti-dsDNA and SLE. Recently, among other mutations, rare null-alleles for the deoxyribonuclease 1 like 3 (DNASE1L3) and the Fc gamma receptor IIB (FCGR2B) have been described in SLE patients and genetic mouse models. Here, we demonstrate that double Dnase1l3- and FcgR2b-deficient mice in the C57BL/6 background exhibit a very early and massive IgG anti-dsDNA production. Already at 10 weeks of age, autoantibody production in double-deficient mice exceeds autoantibody levels of diseased 9-month-old NZB/W mice, a long established multigenic SLE mouse model. In single gene-deficient mice, autoantibody levels were moderately elevated at early age of the mice. Premature autoantibody production was accompanied by a spontaneous hyperactivation of germinal centers, early expansions of T follicular helper cells, and elevated plasmablasts in the spleen. Anti-dsDNA hybridomas generated from double-deficient mice show significantly elevated numbers of arginines in the CDR3 regions of the heavy-chain as well as clonal expansions and diversification of B cell clones with moderate numbers of somatic mutations. Our findings show a strong epistatic interaction of two SLE-alleles which prevent early and high-level anti-dsDNA autoantibody production. Both genes apparently synergize to keep in check excessive germinal center reactions evolving into IgG anti-dsDNA antibody producing B cells.

Highlights

  • The formation of antibodies against DNA is considered to be the serologic hallmark of systemic lupus erythematosus (SLE)

  • We have proposed earlier that anti-dsDNA antibodies evolve from non-autoreactive progenitors in germinal centers [34, 35] and strong evidence has been accumulated that the Fc γ receptor IIB (FcγRIIB) plays an important role in B cell tolerance in the GC [17]

  • The results described in this study reveal a strong genetic interaction of two individual susceptibility genes for anti-dsDNA autoantibody production in SLE that have been described in familiar lupus, as well as in knockout mouse models

Read more

Summary

Introduction

The formation of antibodies against DNA is considered to be the serologic hallmark of systemic lupus erythematosus (SLE). Autoantibodies against double-stranded DNA (anti-dsDNA) antibodies are the most studied and the most enigmatic autoantibodies in SLE. Their presence correlates with nephritis both in human SLE patients and in mice with a spontaneous lupus-like disease [1,2,3]. Homozygous mutations in the C1q genes are responsible for SLE or SLE-like disease [7] and C1q-deficient mice accumulate apoptotic cells in several tissues and develop anti-DNA autoantibodies and SLE in certain genetic backgrounds but not in the C57BL/6 background [8, 9]. Homozygous mutations in the TREX1 gene encoding a DNA exonuclease present in the cytoplasm are associated with the Aicardi–Goutieres syndrome-1 with increased systemic type I interferon levels and antinuclear autoantibodies [10]. Trex1-deficient mice develop autoantibodies and SLE-like disease

Methods
Results
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call